APC, adenomatous polyposis coli; CBP, cAMP-response element binding protein; CIBP, calcium- and integrin-binding protein; CK, creatine kinase. CtBP, C-terminal binding protein; GRO, growth-regulated ...
Researchers have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal ...
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited ...
In patients with familial adenomatous polyposis, a genetic disease predisposing to colon cancer, mutations of the APC gene induce the formation of intestinal polyps, but also reduce immune system ...
Familial adenomatous polyposis (FAP) is a rare condition that predisposes you (makes you more susceptible) to precancerous colorectal adenomatous polyps. Adenomatous polyps are abnormal growths that ...
Recursion, a clinical-stage TechBio company, is set to present preliminary data from its Phase 1b/2 clinical trial, TUPELO, at the 2025 Digestive Disease Week (DDW) meeting on May 4, 2025, in San ...
Tempest Therapeutics, Inc. has announced that the FDA has granted Orphan Drug Designation to its dual receptor inhibitor TPST-1495 for treating Familial Adenomatous Polyposis (FAP), a rare genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback